Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory Board
Philadelphia, PA, February 24, 2020 – Renovacor, Inc, a preclinical-stage biopharmaceutical company focused on developing...
Search for Articles
Feb 24, 2020
Feb 6, 2020
Aria CV Receives FDA Breakthrough Designation for Its Medical Device for Treating Pulmonary Arterial Hypertension
February 06, 2020 07:00 AM Eastern Standard Time SAINT PAUL, Minn.--(BUSINESS WIRE)--Aria CV, Inc., a...
Nov 5, 2019
Aeromics and Simcere Announce Collaboration and License Agreement for AER-271 in Greater China
November 5, 2019 3:30pm Eastern Daylight Time NEW HAVEN, Conn. and NANJING, China, (PRNewswire.com) -...
Nov 4, 2019
Kantum Pharma Founder to Present Preclinical Data Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury at the American Society of Nephrology Annual Meeting
November 4, 2019 3:30pm Eastern Daylight Time CAMBRIDGE, MA (Newswire.com) - Kantum Pharma Inc., a...
Sep 12, 2019
CroíValve Secures €4M in Additional Funding to Initiate Clinical Trials
September 12, 2019 07:00 AM Eastern Daylight Time DUBLIN (BUSINESS WIRE)– €4 million in additional...
Aug 14, 2019
Renovacor Closes $11 Million Series A Financing to Advance First Gene Therapy for a Rare Cardiovascular Disease
August 14, 2019 07:00 AM Eastern Daylight Time PHILADELPHIA--(BUSINESS WIRE)--Renovacor, Inc, a preclinical-stage biopharmaceutical company focused...